about
Alterations in anatomic and functional imaging parameters with repeated FDG PET-CT and MRI during radiotherapy for head and neck cancer: a pilot study.Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma.Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma.Clinical impact of (18)F-FDG PET-CT in recurrent stage III/IV melanoma: a tertiary centre Specialist Skin Cancer Multidisciplinary Team (SSMDT) experience.Functional imaging for radiation treatment planning, response assessment, and adaptive therapy in head and neck cancer.Life-threatening rectal bleeding due to cytomegalovirus colitis in a haemodialysis patient.The proliferation of multidisciplinary team meetings (MDTMs): how can radiology departments continue to support them all?Diagnostic and response assessment FDG PET-CT in neurolymphomatosisNo longer any role for routine follow-up chest x-rays in men with stage I germ cell cancer.Delayed response assessment with FDG-PET-CT following (chemo) radiotherapy for locally advanced head and neck squamous cell carcinoma.F-18 FDG PET/CT imaging of follicular dendritic cell sarcoma of the mediastinum.British Thoracic Society guidelines for the investigation and management of pulmonary nodules.Recurrent Malignant Melanoma Detected on 18F-Fluciclovine PET/CT Imaging for Prostate Cancer.British Thoracic Society quality standards for the investigation and management of pulmonary nodules.Design and implementation of a web-based PET-CT reporting assessment and e-portfolio tool.Pulmonary artery embolization for recurrent haemoptysis in cavitatory sarcoidosis.Who should have pelvic vessel imaging prior to renal transplantation?Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanomaActive cardiac sarcoidosis on standard chest computed tomography18F-FDG PET/CT Detected Delayed Endoleak in an Aortoiliac Endovascular Aneurysm RepairThe effect of a novel Bayesian penalised likelihood PET reconstruction algorithm on the assessment of malignancy risk in solitary pulmonary nodules according to the British Thoracic Society guidelinesLong-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern eraUK guidelines on 18F-fluciclovine PET/CT in prostate cancer imaging
P50
Q35219168-5673833F-421F-4BB0-991D-C5A70F08F71AQ35830998-1A27DBC1-CFC3-4540-8C61-D69EF0A0B64AQ36295724-D5682A12-B284-4C33-9F2A-D128B35194F0Q37192805-05E2D774-835E-4081-A6F3-4EB1CBF38F27Q38162269-7293C3D5-2C37-4DD7-9443-857B71C0589CQ38487292-4A37F27F-12B0-4AA2-B769-62C6325F7AFBQ40991252-ADAE737C-54EE-40E5-8DED-5BD547B60ECAQ42359788-4DFD7EC4-454E-4E0C-B1C7-EC4F752EB9C7Q48596329-7846B69C-4490-4E0A-A3C8-A287995EDAD7Q49189798-5E47041F-C343-4142-A061-D5C36589E080Q51369573-1F58C91A-76D2-473F-B91F-DE3F10378CCBQ51621075-26596169-4C5F-4A60-803D-24AAE5303370Q51808266-51FED6B4-D2BD-413D-89B1-6971C5D02DC3Q52801763-BACE14AA-1435-45C4-B1A6-E42F2763D844Q52838276-0B96177A-B38E-4D21-8702-0AB69490340BQ52846250-23BBB3DD-B185-4540-AAC5-0FD39AE09C8EQ52847971-A6B4F8A7-DB23-4537-B59E-E027BC604BD5Q69338089-C3D4979A-3D8F-44E8-A14C-8E5D527EFA4DQ88961374-69A731DE-EDEB-4410-B359-6C2E4321B2FEQ89934101-A186AE06-BBE6-4416-81E4-AD9674D7542CQ91897025-E8D7C7BB-3AE5-483F-9D8B-9B11DE189EF6Q92121455-5D917307-80B3-424C-A73E-D0622B538D6AQ92400112-93F37440-B88E-44CF-AF42-A72D70564428
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Manil Subesinghe
@ast
Manil Subesinghe
@en
Manil Subesinghe
@es
Manil Subesinghe
@nl
Manil Subesinghe
@sl
type
label
Manil Subesinghe
@ast
Manil Subesinghe
@en
Manil Subesinghe
@es
Manil Subesinghe
@nl
Manil Subesinghe
@sl
prefLabel
Manil Subesinghe
@ast
Manil Subesinghe
@en
Manil Subesinghe
@es
Manil Subesinghe
@nl
Manil Subesinghe
@sl
P106
P31
P496
0000-0002-5688-0153